2020甲状腺结节超声恶性危险分层中国指南:C-TIRADS

2021-03-30 中华医学会超声医学分会 中华超声影像学杂志.2021.30(3):185-200.

甲状腺结节非常多见,19%~68%的普通人群超声可测及甲状腺结节,其中大多数为不具有临床意义的良性结节。在中国,通过超声检查发现甲状腺结节的患病率约20%~35%。根据年龄、性别、受辐射史、家族史和其

中文标题:

2020甲状腺结节超声恶性危险分层中国指南:C-TIRADS

发布日期:

2021-03-30

简要介绍:

甲状腺结节非常多见,19%~68%的普通人群超声可测及甲状腺结节,其中大多数为不具有临床意义的良性结节。在中国,通过超声检查发现甲状腺结节的患病率约20%~35%。根据年龄、性别、受辐射史、家族史和其他因素的不同,甲状腺结节患者7%~15%为甲状腺癌。超声检查作为甲状腺结节首选的影像学检查方法,在临床诊疗决策中具有重要的价值。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2020甲状腺结节超声恶性危险分层中国指南:C-TIRADS.pdf)] GetToolGuiderByIdResponse(projectId=1, id=a2c941c0021001ce, title=2020甲状腺结节超声恶性危险分层中国指南:C-TIRADS, enTitle=, guiderFrom=中华超声影像学杂志.2021.30(3):185-200., authorId=0, author=, summary=甲状腺结节非常多见,19%~68%的普通人群超声可测及甲状腺结节,其中大多数为不具有临床意义的良性结节。在中国,通过超声检查发现甲状腺结节的患病率约20%~35%。根据年龄、性别、受辐射史、家族史和其, cover=https://img.medsci.cn/2021518/1621268259606_2020535.jpg, journalId=0, articlesId=null, associationId=1057, associationName=中华医学会超声医学分会, associationIntro=null, copyright=0, guiderPublishedTime=Tue Mar 30 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>甲状腺结节非常多见,19%~68%的普通人群超声可测及甲状腺结节,其中大多数为不具有临床意义的良性结节。在中国,通过超声检查发现甲状腺结节的患病率约20%~35%。根据年龄、性别、受辐射史、家族史和其他因素的不同,甲状腺结节患者7%~15%为甲状腺癌。超声检查作为甲状腺结节首选的影像学检查方法,在临床诊疗决策中具有重要的价值。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=7217, tagName=甲状腺结节)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=40, categoryName=影像放射, tenant=100), CategoryDto(categoryId=73, categoryName=头颈外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=7217, guiderKeyword=甲状腺结节, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=13370, appHits=1129, showAppHits=0, pcHits=4200, showPcHits=12239, likes=8, shares=103, comments=51, approvalStatus=1, publishedTime=Tue May 18 00:22:12 CST 2021, publishedTimeString=2021-03-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue May 18 00:17:46 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 16:41:14 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020甲状腺结节超声恶性危险分层中国指南:C-TIRADS.pdf)])
2020甲状腺结节超声恶性危险分层中国指南:C-TIRADS.pdf
下载请点击:
评论区 (42)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2100101, encodeId=1a2b2100101c6, content=可以 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96668427759, createdName=ms6000001932008167, createdTime=Sat Nov 12 16:19:38 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092643, encodeId=2323209264388, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c411873967, createdName=ms3408309559718063, createdTime=Sun Oct 09 11:25:38 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241366, encodeId=3159124136658, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13415846416, createdName=zhouyusu0713, createdTime=Sat Aug 27 13:31:55 CST 2022, time=2022-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239941, encodeId=51a11239941da, content=学习了,很不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e0a2986748, createdName=24578318, createdTime=Sat Aug 20 08:57:21 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224481, encodeId=84ed122448140, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca85436531, createdName=ms7000000017147997, createdTime=Sat Jun 04 22:35:41 CST 2022, time=2022-06-04, status=1, ipAttribution=)]
    2022-11-12 ms6000001932008167

    可以

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2100101, encodeId=1a2b2100101c6, content=可以 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96668427759, createdName=ms6000001932008167, createdTime=Sat Nov 12 16:19:38 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092643, encodeId=2323209264388, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c411873967, createdName=ms3408309559718063, createdTime=Sun Oct 09 11:25:38 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241366, encodeId=3159124136658, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13415846416, createdName=zhouyusu0713, createdTime=Sat Aug 27 13:31:55 CST 2022, time=2022-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239941, encodeId=51a11239941da, content=学习了,很不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e0a2986748, createdName=24578318, createdTime=Sat Aug 20 08:57:21 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224481, encodeId=84ed122448140, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca85436531, createdName=ms7000000017147997, createdTime=Sat Jun 04 22:35:41 CST 2022, time=2022-06-04, status=1, ipAttribution=)]
    2022-10-09 ms3408309559718063

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2100101, encodeId=1a2b2100101c6, content=可以 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96668427759, createdName=ms6000001932008167, createdTime=Sat Nov 12 16:19:38 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092643, encodeId=2323209264388, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c411873967, createdName=ms3408309559718063, createdTime=Sun Oct 09 11:25:38 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241366, encodeId=3159124136658, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13415846416, createdName=zhouyusu0713, createdTime=Sat Aug 27 13:31:55 CST 2022, time=2022-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239941, encodeId=51a11239941da, content=学习了,很不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e0a2986748, createdName=24578318, createdTime=Sat Aug 20 08:57:21 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224481, encodeId=84ed122448140, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca85436531, createdName=ms7000000017147997, createdTime=Sat Jun 04 22:35:41 CST 2022, time=2022-06-04, status=1, ipAttribution=)]
    2022-08-27 zhouyusu0713

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2100101, encodeId=1a2b2100101c6, content=可以 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96668427759, createdName=ms6000001932008167, createdTime=Sat Nov 12 16:19:38 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092643, encodeId=2323209264388, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c411873967, createdName=ms3408309559718063, createdTime=Sun Oct 09 11:25:38 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241366, encodeId=3159124136658, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13415846416, createdName=zhouyusu0713, createdTime=Sat Aug 27 13:31:55 CST 2022, time=2022-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239941, encodeId=51a11239941da, content=学习了,很不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e0a2986748, createdName=24578318, createdTime=Sat Aug 20 08:57:21 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224481, encodeId=84ed122448140, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca85436531, createdName=ms7000000017147997, createdTime=Sat Jun 04 22:35:41 CST 2022, time=2022-06-04, status=1, ipAttribution=)]
    2022-08-20 24578318

    学习了,很不错

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2100101, encodeId=1a2b2100101c6, content=可以 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96668427759, createdName=ms6000001932008167, createdTime=Sat Nov 12 16:19:38 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092643, encodeId=2323209264388, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c411873967, createdName=ms3408309559718063, createdTime=Sun Oct 09 11:25:38 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241366, encodeId=3159124136658, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13415846416, createdName=zhouyusu0713, createdTime=Sat Aug 27 13:31:55 CST 2022, time=2022-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239941, encodeId=51a11239941da, content=学习了,很不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e0a2986748, createdName=24578318, createdTime=Sat Aug 20 08:57:21 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224481, encodeId=84ed122448140, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca85436531, createdName=ms7000000017147997, createdTime=Sat Jun 04 22:35:41 CST 2022, time=2022-06-04, status=1, ipAttribution=)]
    2022-06-04 ms7000000017147997

    学习

    0

拓展阅读

2016 AACE/ACE/AME指南:甲状腺结节的诊断和管理

美国临床内分泌医师学会(AACE,American Association of Clinical Endocrinologists) · 2016-05-16

2018 KSThR共识声明:甲状腺结节乙醇消融治疗

韩国甲状腺放射学会(KSThR,Korean Society of Thyroid Radiology) · 2019-03-20

2020年欧洲甲状腺协会在良性甲状腺结节中使用图像引导消融的临床实践指南

欧洲甲状腺协会(ETA,European Thyroid Association) · 2020-09-01

中国儿童甲状腺结节及分化型甲状腺癌专家共识

国家儿童医学中心(北京) · 2020-10-30